He will also be eligible for annual long-term incentive grants under the Equity Participation Plan, where for 2017, Woody's target value stands at about $3.54 million and is comprised of $1.42 million in stock options and performance-based restricted share units valued at about $2.12 million. Woody is also entitled to participate in Halyard Health's Executive Officer Achievement Award Plan with a bonus incentive target of 115% over his base pay, earned during the year. Post the execution of the announcement on June 26, 2017, Joseph Woody would have lead the Company with over $1.6 billion revenues in FY17, and about 12,000 employees worldwide.Īccording to the June 23, 2017, SEC filing, Halyard Health disclosed Woody's financial package of $885,000 per annum. He further acted as the driving force behind the expansion of Acelity in new product development and therapy adoption. Woody also guided Acelity through some major transactions, including the reported sale of Acelity's regenerative medicine business, LifeCell Corp., to Allergan in February 2017 for $2.9 billion in cash. Inc.'s business in early 2017, for about $3 billion. Joseph Woody oversaw the divestiture of Acelity I.P.

He holds the required expertise needed to propel Halyard Health forward in the fast-paced industry. Dollens, Halyard Health's independent lead director, Joseph Woody is an experienced healthcare CEO with proven success driving revenue growth and spearheading portfolio transformations during his tenure at Acelity. Woody's entire career has been in the medical technology industry, and until April 2017, he held the position of President and CEO at Acelity, a wound-care Company based in San Antonio, Texas, where he joined the firm in 2011.Īccording to Ronald W. Woody, aged 51, holds more than 20 years of expertise in the health-care sector.

The Board of Directors of Halyard Health has named Joseph Woody as the successor to Abernathy. Halyard Health, a leading medical technology Company, was spun off from Kimberly-Clark Corp.

Woodies protrader